In situ detection of virus- and tumor-specific T-cell immunity

被引：63
作者：
Haanen, JBAG
Van Oijen, MGCT
Tirion, F
Oomen, LCJM
Kruisbeek, AM
Vyth-Dreese, FA
Schumacher, TNM
机构：
[1] Netherlands Canc Inst, Dept Immunol, NL-1066 CX Amsterdam, Netherlands
[2] Netherlands Canc Inst, Dept Cell Biol, NL-1066 CX Amsterdam, Netherlands
来源：
NATURE MEDICINE | 2000年 / 6卷 / 09期
关键词：
D O I：
10.1038/79573
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：1056 / 1060
页数：5
相关论文
共 50 条
  • [21] Tumor-Specific T-cell Help Is Associated with Improved Survival in Melanoma
    Woods, Katherine
    Cebon, Jonathan
    [J]. CLINICAL CANCER RESEARCH, 2013, 19 (15) : 4021 - 4023
  • [22] SINGLE-CHAIN T-CELL RECEPTOR AS A TUMOR-SPECIFIC VACCINE
    WONG, CP
    OKADA, CY
    LEVY, R
    [J]. FASEB JOURNAL, 1995, 9 (03) : A514 - A514
  • [23] Therapeutic vaccine strategies to induce tumor-specific T-cell responses
    Ana Marcu
    Matthias Eyrich
    [J]. Bone Marrow Transplantation, 2019, 54 : 806 - 809
  • [24] Tumor-specific delivery of biologics by a novel T-cell line HOZOT
    Teppei Onishi
    Hiroshi Tazawa
    Yuuri Hashimoto
    Makoto Takeuchi
    Takeshi Otani
    Shuji Nakamura
    Fuminori Sakurai
    Hiroyuki Mizuguchi
    Hiroyuki Kishimoto
    Yuzo Umeda
    Yasuhiro Shirakawa
    Yasuo Urata
    Shunsuke Kagawa
    Toshiyoshi Fujiwara
    [J]. Scientific Reports, 6
  • [25] Therapeutic vaccine strategies to induce tumor-specific T-cell responses
    Marcu, Ana
    Eyrich, Matthias
    [J]. BONE MARROW TRANSPLANTATION, 2019, 54 (Suppl 2) : 806 - 809
  • [26] Tumor-specific delivery of biologics by a novel T-cell line HOZOT
    Onishi, Teppei
    Tazawa, Hiroshi
    Hashimoto, Yuuri
    Takeuchi, Makoto
    Otani, Takeshi
    Nakamura, Shuji
    Sakurai, Fuminori
    Mizuguchi, Hiroyuki
    Kishimoto, Hiroyuki
    Umeda, Yuzo
    Shirakawa, Yasuhiro
    Urata, Yasuo
    Kagawa, Shunsuke
    Fujiwara, Toshiyoshi
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [27] IMPLICATIONS OF LEUKOREGULIN TO AUTOLOGOUS TUMOR-SPECIFIC HUMAN T-CELL POPULATIONS
    SLINGLUFF, CL
    SEIGLER, HF
    DARROW, TL
    EVANS, CH
    [J]. JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1990, 9 (04): : 387 - 394
  • [28] Priming or tolerization of tumor-specific T cell immunity; Lessons from murine tumor models
    Offringa, R
    Toes, REM
    Schoenberger, SP
    Melief, CJM
    [J]. SPECIFIC IMMUNOTHERAPY OF CHRONIC AUTOIMMUNE DISEASES: HOW TO TRANSLATE THE EXPERIENCE OF THE EXPERIMENTAL MODELS INTO NOVEL TREATMENT MODALITIES, 1999, : 41 - 49
  • [29] CELL-SURFACE MODIFICATION OF TUMOR-CELL BY NEWCASTLE-DISEASE VIRUS LEADS TO AUGMENTED TUMOR-SPECIFIC T-CELL RESPONSES
    SCHIRRMACHER, V
    VONHOGEN, P
    SCHILD, H
    [J]. CANCER AND METASTASIS REVIEWS, 1989, 8 (02) : 171 - 172
  • [30] TUMOR-SPECIFIC CELLULAR IMMUNITY
    COHEN, AM
    BURDICK, JF
    KETCHAM, AS
    [J]. JOURNAL OF SURGICAL RESEARCH, 1971, 11 (08) : 421 - +
12345